Rapid Micro Biosystems, Inc. last reported quarterly results on Aug 7, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $8.1 million (+10.9% year over year) and diluted EPS of -$0.27. It usually reports 13–43 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 6, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Friday. Based on last year's release for the same quarter on Nov 7, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 13–43 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 7, 2026
38 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
8
+10.9%
|
-13
-9.0%
|
-0.27
+0.0%
|
|
May 13, 2026
43 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
8
+11.1%
|
-14
-26.7%
|
-0.31
-19.2%
|
|
Jan 13, 2026
13 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
11
+37.3%
|
-12
-29.3%
|
-0.28
-25.5%
|
|
Nov 7, 2025
38 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
8
+3.1%
|
-12
-1.6%
|
-0.26
+0.0%
|
|
Aug 12, 2025
43 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
7
+9.7%
|
-12
+5.7%
|
-0.27
+6.9%
|
|
May 9, 2025
39 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
7
+28.4%
|
-11
+15.5%
|
-0.26
+16.1%
|
|
Jan 14, 2025
14 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
8
+29.7%
|
-10
+13.5%
|
-0.22
+14.7%
|
|
Nov 1, 2024
32 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
8
+23.7%
|
-11
+15.4%
|
-0.26
+16.1%
|
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- RPID (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lexington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1380106
- Former names
- RAPID MICRO BIOSYSTEMS INC (until Jul 15, 2009)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.